Answers are grounded in this paper and cite their sources.
Repurposing very poorly soluble drug compounds for new administration routes is highly challenging; however, we present nebulisable aqueous drug particle dispersions of two agents with appreciable anti SARS-CoV-2 activity for pulmonary delivery.
No takes yet. Share an insight, caveat, or question.
Unsworth et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: